Another study by Borelli et al. showed that a MLH1 (c.2252_2253delAA) mutation in patients with Lynch syndrome is associated with an increased risk of pancreatic tumors, with 5 patients having pancreatic cancer out of a total of 67 patients with Lynch syndrome [26]. This evidence concerns the gene MLH1 and pancreatic neoplasm.